268 related articles for article (PubMed ID: 28671000)
1. Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study.
Kudlek Mikulic S; Mihaljevic-Peles A; Sagud M; Bajs Janovic M; Ganoci L; Grubisin J; Kuzman Rojnic M; Vuksan Cusa B; Bradaš Z; Božina N
Nord J Psychiatry; 2017 Oct; 71(7):513-520. PubMed ID: 28671000
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
Lee BH; Kim YK
Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
[TBL] [Abstract][Full Text] [Related]
4. Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics.
Rizos EN; Papadopoulou A; Laskos E; Michalopoulou PG; Kastania A; Vasilopoulos D; Katsafouros K; Lykouras L
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):251-5. PubMed ID: 20218789
[TBL] [Abstract][Full Text] [Related]
5. Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients.
Yoshimura R; Ueda N; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):256-61. PubMed ID: 20218790
[TBL] [Abstract][Full Text] [Related]
6. Fasting insulin serum levels and psychopathology profiles in male schizophrenic inpatients treated with olanzapine or risperidone.
Konarzewska B; Waszkiewicz N; Galińska B; Szulc A
Neuro Endocrinol Lett; 2013; 34(4):322-8. PubMed ID: 23803867
[TBL] [Abstract][Full Text] [Related]
7. Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients.
Nikolac Perkovic M; Nedic Erjavec G; Zivkovic M; Sagud M; Uzun S; Mihaljevic-Peles A; Kozumplik O; Muck-Seler D; Pivac N
Psychopharmacology (Berl); 2014 Sep; 231(18):3757-64. PubMed ID: 24595507
[TBL] [Abstract][Full Text] [Related]
8. Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients.
Yoshimura R; Hori H; Sugita A; Ueda N; Kakihara S; Umene W; Nakano Y; Shinkai K; Mitoma M; Ohta M; Shinkai T; Nakamura J
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1072-7. PubMed ID: 17459549
[TBL] [Abstract][Full Text] [Related]
9. Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics.
Chiou YJ; Huang TL
World J Biol Psychiatry; 2017 Aug; 18(5):382-391. PubMed ID: 27643618
[TBL] [Abstract][Full Text] [Related]
10. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
Pirildar S; Gönül AS; Taneli F; Akdeniz F
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
[TBL] [Abstract][Full Text] [Related]
11. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
[TBL] [Abstract][Full Text] [Related]
12. Effects of Risperidone and Paliperidone on Brain-Derived Neurotrophic Factor and N400 in First-Episode Schizophrenia.
Wu RQ; Lin CG; Zhang W; Lin XD; Chen XS; Chen C; Zhang LJ; Huang ZY; Chen GD; Xu DL; Lin ZG; Zhang MD
Chin Med J (Engl); 2018 Oct; 131(19):2297-2301. PubMed ID: 30246715
[TBL] [Abstract][Full Text] [Related]
13. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study.
Wampers M; Hanssens L; van Winkel R; Heald A; Collette J; Peuskens J; Reginster JY; Scheen A; De Hert M
Eur Neuropsychopharmacol; 2012 Jan; 22(1):17-26. PubMed ID: 21511441
[TBL] [Abstract][Full Text] [Related]
15. BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study.
Wu ZW; Shi H; Chen DC; Chen S; Xiu MH; Zhang XY
Psychoneuroendocrinology; 2020 Dec; 122():104879. PubMed ID: 33049658
[TBL] [Abstract][Full Text] [Related]
16. Effects of antipsychotics on the serum BDNF levels in schizophrenia.
Chen CC; Huang TL
Psychiatry Res; 2011 Oct; 189(3):327-30. PubMed ID: 21320726
[TBL] [Abstract][Full Text] [Related]
17. Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia.
Yasui-Furukori N; Saito M; Nakagami T; Sugawara N; Sato Y; Tsuchimine S; Furukori H; Kaneko S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):537-40. PubMed ID: 20170699
[TBL] [Abstract][Full Text] [Related]
18. Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics.
González-Pinto A; Mosquera F; Palomino A; Alberich S; Gutiérrez A; Haidar K; Vega P; Barbeito S; Ortiz A; Matute C
Int Clin Psychopharmacol; 2010 Jul; 25(4):241-5. PubMed ID: 20568658
[TBL] [Abstract][Full Text] [Related]
19. Comparison between risperidone, olanzapine, and clozapine in the management of chronic schizophrenia: a naturalistic prospective 12-week observational study.
Strous RD; Kupchik M; Roitman S; Schwartz S; Gonen N; Mester R; Weizman A; Spivak B
Hum Psychopharmacol; 2006 Jun; 21(4):235-43. PubMed ID: 16783815
[TBL] [Abstract][Full Text] [Related]
20. Risperidone and olanzapine versus another first generation antipsychotic in patients with schizophrenia inadequately responsive to first generation antipsychotics.
Chen JJ; Chan HY; Chen CH; Gau SS; Hwu HG
Pharmacopsychiatry; 2012 Mar; 45(2):64-71. PubMed ID: 22086749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
